LONA · NASDAQ · Biotechnology

LeonaBio (LONA)

Develops lasofoxifene for metastatic breast cancer and ATH-1105 for ALS.

$6.05
After-hours close+0.07 (+1.17%)
At close$5.98(−5.53%)